Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05463809
Other study ID # Han Liu
Secondary ID
Status Not yet recruiting
Phase Phase 3
First received
Last updated
Start date July 14, 2022
Est. completion date June 1, 2024

Study information

Verified date June 2022
Source Nanjing First Hospital, Nanjing Medical University
Contact Jie Wei
Phone 18752113232
Email 961683175@qq.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to evaluate the efficacy and safety of a continuous gastrocnemius plane block for perioperative analgesia in patients undergoing foot and ankle surgery under elective general anesthesia.


Description:

Anatomical studies show that the 0.2% methylene blue was injected into the upper and lower surface of the gastrocnemius muscle and then diffused to the periphery.The common peroneal nerve, the medial sural cutaneous nerve, the lateral sural cutaneous nerve and the tibial nerve below the gastrocnemius muscle are all strongly stained (3 / 4 color of the nerve) or fully stained. Previous clinical studies have shown that a single gastrocnemius muscle plane block can provide good postoperative analgesia after 16 hours for patients with foot and ankle surgery, significantly reduce the dose of opioids, and see no nerve injury. Therefore, the investigators hypothesized that continuous gastrocnemius plane block could provide more lasting analgesia in patients undergoing foot-ankle surgery. This clinical study uses a single-center, randomized, single-blind, parallel controlled trial design, divided into screening period, treatment period and follow-up periods. Patients were randomized into two groups, the ropivacaine group and the control group.The venous access was open after home invasion and was routinely monitored electrocardiogram(ECG), non-invasive blood pressure(NBP) ,oxygen saturation(SpO2),bispectral index(BIS). General anesthesia was performed. Induction of anesthesia: propofol 1 milligram / kg, cis atracurium 0.2 milligrams / kilogram, sufentanil 10 micrograms ,remifentanil at 1.5 micrograms/ kilogram. Anesthesia maintenance: Propofol and sevoflurane static aspiration compound bispectral index was maintained at 40~60, remifentanil 0.3~0.4 μg / kg/min intravenous pump, and additional cis atracurium was added according to neuromuscular monitoring. In the postoperative ropivacaine group, the patient took a lateral decubitus position, and underwent a gastrocnemius plane block and catheterization under ultrasound guidance to connect a disposable electron infusion pump. (Formula of 0.125% ropivacaine of 300 milliliters, background dose of 3.0 milliliters / hour, patient controlled analgesia(PCA) dose of 8 milliliters , and locking time of 25 minutes). The control group received intravenous oxycodone titrated according to the numerical rating scale (NRS) score, and received no background dose of oxycodone patient-controlled intravenous analgesia (PCIA) pump for analgesia (single dose 1milligram, locking time 5minutes, 4 hours limit 12milligrams). All patients were given 50 milligrams of fluorophenol ester intravenously. Remedial analgesia: if patient controlled analgesia still can not tolerate the pain and numerical rating scale(NRS) ≥4, can be given intravenously oxycodone was done 2milligrams, separated by over 3 minutes, until numerical rating scale(NRS) ≤3. Record: block range of 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 1 hour, 4 hours, 8 hours, 12 hours, 24 hours, 48hours and numerical rating scale(NRS) score during rest and exercise; time of first pressing of the analgesic pump; times of controlled analgesia (PCA); 0-4 hours, 0-8 hours, 0-16 hours, 0-24 hours, 8-16 hours, 16-24 hours, 24-32 hours, 32-40 hours,40-48 hours pain intensity-time curve (AUC); dose and times of remedial analgesic administration; Records: affected limb muscle strength and paresthesia, length of hospitalization, time of first ambulation, nausea and vomiting, neurological complications, patient satisfaction, physician and nurse satisfaction, etc. The patient had open venous access after home invasion and was routinely monitored for electrocardiogram(ECG), non-invasive blood pressure(NBP) ,oxygen saturation(SpO2) and bispectral index(BIS). Induction and maintenance were performed according to a uniform anesthesia protocol. Postoperatively, the block was performed by the same anesthesiologist familiar with the ultrasound-guided nerve block. Various study indicators and data were collected by the same anesthesiologist who was not aware of the grouping situation.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date June 1, 2024
Est. primary completion date January 30, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Patients undergoing elective foot and ankle surgery - Patient informed consent was obtained - Age 18 to 65 years Sex is not limited - American Society of Anesthesiologists(ASA)?~? level - Body Mass Index(BMI)18~28kg/m2 Exclusion Criteria: - Puncture site infection - Abnormal coagulation function - Local anesthetic allergy - Severe cardiopulmonary disease - Liver and renal insufficiency - Medical history of chronic pain - Long-term use of sedative and analgesic drugs - Communication disorders - The operation time exceeded 3 hours

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Continuous Gastrocnemius plane block with ropivacaine
After extubation, the patient was routinely monitored for his vital signs.The nerve block operation was performed by the same doctor: let the patient take the lateral decubitus position, use the ultrasonic high-frequency array probe under the popliteal socket to scan the sciatic nerve, move the probe down to find the tibial nerve and the common peroneal nerve, and then a single injection of 0.375% Ropivacaine 15milliliters was given into the common peroneal nerve, medial sural cutaneous nerve, and lateral sural cutaneous nerve. Then avoid common peroneal nerve, use the indwelling needle (16GA 3.25 IN), and put the catheter after saline expansion.
oxycodone
The patient was revived and received intravenous oxycodone titration according to the numerical rating scale (NRS) score, and was treated with no background dose of oxycodone patient-controlled intravenous analgesia (PCIA) pump for analgesia.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Nanjing First Hospital, Nanjing Medical University

References & Publications (8)

Anderson JG, Bohay DR, Maskill JD, Gadkari KP, Hearty TM, Braaksma W, Padley MA, Weaver KT. Complications After Popliteal Block for Foot and Ankle Surgery. Foot Ankle Int. 2015 Oct;36(10):1138-43. doi: 10.1177/1071100715589741. Epub 2015 Jun 24. — View Citation

Bai Shu order, should be dajun et al. descriptive anatomy. The People's Health Publishing House. 353-357.

Dong Guangyu, Huang Bingzhe, Zhang Hanyang, Chang Fei. Ankle joint block treatment. The Electronic Journal of Foot and Ankle Surgery. 2017, 4(3):59.

Gartke K, Portner O, Taljaard M. Neuropathic symptoms following continuous popliteal block after foot and ankle surgery. Foot Ankle Int. 2012 Apr;33(4):267-74. doi: 10.3113/FAI.2012.0267. — View Citation

Provenzano DA, Viscusi ER, Adams SB Jr, Kerner MB, Torjman MC, Abidi NA. Safety and efficacy of the popliteal fossa nerve block when utilized for foot and ankle surgery. Foot Ankle Int. 2002 May;23(5):394-9. — View Citation

Qiu Wen, Yu Bin. Randomized controlled study of continuous popliteal sciatic nerve block analgesia and intravenous analgesia after foot and ankle surgery. Journal of Tongji University (Medical edition), 2 018,39 (02): 99-102.

Sun Li, Wei Jinju. Patient VAS was scored by ultrasound-guided continuous sciatic nerve block during foot surgery And the effect analysis of morphine dosage. Journal of Mathematical Medicine, 2019,32 (4): 523-524.

Zhang Jinfang, Li Yimei. Ultrasound-guided continuous popliteal sciatic nerve block for postoperative analgesia in patients undergoing foot and ankle surgery. The World's Latest Medical Information Abstract, 2019,19 (68): 1-3.

Outcome

Type Measure Description Time frame Safety issue
Other The incidence of muscle strength and sensory abnormalities in the affected limb The lower the incidence of muscle strength and sensory abnormalities in the affected limb, the better the effect of continuous gastrocnemius plane block Up to 48 hours postoperative
Other The incidence of adverse reactions, such as nausea, vomiting, and neurological complications The lower the incidence of adverse effects such as nausea, vomiting, and neurological complications, the better the continuous gastrocnemius plane block technique Up to 48 hours postoperative
Other First time to get out of bed First bedtime helps to judge the effect of the nerve block Up to 48 hours postoperative
Other The incidence of adverse events Prevent adverse events such as catheter leakage and shedding Up to 48 hours postoperative
Other Patient satisfaction score Rated on a 0-10 scale, with a higher score representing greater satisfaction. Up to 48 hours postoperative
Other The incidence of outbreak pain Patients with a single nerve block will have a burst of pain phenomenon, so we need to record the presence of a postoperative burst of pain phenomenon in patients with consecutive blocks Up to 7 days postoperative
Primary Area under the pain intensity-time curve The smaller the area under the pain intensity-time curve, the better the nerve block effect Up to 48 hours postoperative
Secondary Percentage of subjects without remedial analgesics The greater the percentage of subjects without remedial analgesics, the better the nerve block Up to 48 hours postoperative
Secondary The cumulative amount of remedial analgesic drugs (oxycodone) used The smaller the cumulative amount of remedial analgesic drugs, the better the nerve blockade Up to 48 hours postoperative
Secondary Number of remedial analgesia The less the remedial analgesia is, the better the nerve blockade is Up to 48 hours postoperative
Secondary Number of effective patient controlled analgesia (PCA) compressions Number of effective patient controlled analgesia (PCA) compressions Up to 48 hours postoperative
Secondary The proportion of the number of invalid presses to the total presses A smaller proportion of ineffective presses to total presses indicates a better nerve block Up to 48 hours postoperative
Secondary Total number of patient controlled analgesia (PCA) presses Total number of patient controlled analgesia (PCA) presses Up to 48 hours postoperative
See also
  Status Clinical Trial Phase
Completed NCT05444192 - Comparing Clinical Outcomes Using Two Insole Manufacture Techniques N/A
Completed NCT03307499 - NeoPatch Used as Adjunct in Foot and Ankle Tendon Surgery N/A
Withdrawn NCT03522753 - Staple Versus Suture Closure for Foot and Ankle Surgery N/A
Completed NCT05353114 - Clinical Efficacy of a 3D Foot Scanner for the Therapeutic Footwear Fitting N/A
Not yet recruiting NCT04128254 - A Prospective Study in Chinese Patients With Lower Extremity Ankle Fracture of Oral Anticoagulants to Prevent Venous Thromboembolism (VTE) Phase 4